Contrasting SPK Acquisition (NASDAQ:SPK) and Ikena Oncology (NASDAQ:IKNA)
Ikena Oncology (NASDAQ:IKNA – Get Rating) and SPK Acquisition (NASDAQ:SPK – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based
SPK Acquisition Terminates Merger Agreement With Varian Biopharmaceuticals
01:52 PM EST, 12/27/2022 (MT Newswires) -- SPK Acquisition (SPK) said it terminated its merger agreement with Varian Biopharmaceuticals. SPK said in a regulatory filing it sent a notice to Varian term
SPAC SPK Scraps Merger With Varian, Will Liquidate Instead on Dec. 29
SPK Acquisition Corp. On Dec. 21 Sent Varian Notice That SPK Had Terminated The Merger Agreement, Alleging 'Certain Breaches by Varian of One or More Covenants Contained in the Merger Agreement.'
SPK Acquisition Corp. On Dec. 21 Sent Varian Notice That SPK Had Terminated The Merger Agreement, Alleging 'certain breaches by Varian of one or more covenants contained in the Merger Agreement.'
SPK Acquisition Corp. (NASDAQ:SPK) Short Interest Update
SPK Acquisition Corp. (NASDAQ:SPK – Get Rating) was the recipient of a significant increase in short interest in November. As of November 15th, there was short interest totalling 1,100 shares, an in
Varian Biopharmaceuticals to go public through merger with SPAC SPK Acquisition
Varian Biopharmaceuticals plans to go public through a merger with SPAC SPK Acquisition Corp (NASDAQ:SPK). The combined company's post-transaction equity value is expected to be around $116M. The dea
SPK Acquisition Enters Deal to Merge With Varian Biopharmaceuticals
09:51 AM EST, 02/14/2022 (MT Newswires) -- SPK Acquisition Corp. (SPK) said Monday it has agreed to merge with privately owned Varian Biopharmaceuticals to create a combined company with an expected
BRIEF-Varian Biopharmaceuticals, Inc To Become Publicly Traded Through A Merger With Spk Acquisition Corp.
Feb 14 (Reuters) - SPK Acquisition Corp SPK.O :* VARIAN BIOPHARMACEUTICALS, INC., A PRECISION ONCOLOGY COMPANY, TO BECOME PUBLICLY TRADED THROUGH A MERGER WITH SPK ACQUISITION CORP.* SPK ACQUISITION
SPK Acquisition in Deal to Take Varian Bio Public
By Chris Wack SPK Acquisition Corp. on Monday said it was in a deal to make Varian Biopharmaceuticals Inc. a publicly traded company. The special purpose acquisition company said Varian B
Spark New Zealand (NZSE:SPK) shareholders have earned a 13% CAGR over the last five years
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd like to see the share price move up more than the market average. ButSpark New Z
No Data